NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells)
G_NFKBWhat does this word mean?
A central regulator of the inflammatory response, which PDRN suppresses to reduce inflammation.
Expanded note
Inflammation is not purely harmful, since excessive inflammation further damages tissue and slows healing. PDRN's anti-inflammatory action operates on two levels: reducing the synthesis of pro-inflammatory cytokines and directly inhibiting inflammatory signalling pathways such as NF-kB. The site classifies this under tissue effects rather than the signalling cascade, because it describes an outcome rather than a pathway.
Not a generic example.
PMID 39363656, a canine osteoarthritis cell model, shows PDRN suppressing NF-kB and pro-inflammatory cytokine synthesis.
Related terms
Where this term appears
Educational reference only. This site does not provide medical advice, treatment courses, injection counts, clinic recommendations or price recommendations.
PDRN is not approved by the FDA for injection or any therapeutic use. Topical and injectable PDRN are parallel facts under different regulatory pathways and must not be directly equated.
PN is not PDRN. Evidence grades are labelled on every factual element; in vitro and animal research is never described as clinical efficacy.